The newest generation of antiobesity medications (AOMs)—GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), dual action GLP-1/GIP combinations, triple action injectables, and emerging injectable and oral medications—have changed the landscape for weight management, bringing weight loss success to many for whom weight maintenance had previously not been possible.
Trending
- Life After Antiobesity Medications
- Preventing and Treating Diabetic Retinopathy
- Popular Herbal Supplements for Athletes
- The Impact of Regenerative Agriculture
- CPE Monthly: The Influence of Omega-3 Fatty Acids on Inflammatory Markers in Metabolic Syndrome
- Editor’s Spot: Sculpting Behavior
- Education: Nudging Healthier Habits
- Food for Thought: Which Processed Foods Deserve a Spot on Your Plate?